Renal iron expression and urinary transferrin excretion in lupus nephritis: A case-control study
- 9 October 2025
- journal article
- Published by SAGE Publications in Lupus
- Vol. 34 (13) , 1362-1368
Abstract
Background: Lupus nephritis (LN) is a key manifestation of systemic lupus erythematosus (SLE). Aim of the work: To assess urinary transferrin level, renal iron accumulation and transferrin receptor (TfR) gene expression in SLE. Patients and methods: A case-control study was conducted on 80 SLE patients (40 with LN and 40 without LN), and 90 age and sex matched healthy control. Iron markers (Serum iron, ferritin, TfR gene, and urinary transferrin) were assessed in all participants. Iron accumulation and TfR gene expression were evaluated in renal biopsy for LN cases. Disease activity was assessed by Systemic Lupus Erythematosus Disease Activity Index-2K(SLEDAI2k). Results: Of 80 patients, 85% were female. Mean SLEDAI was 15.0525 ± 1.1592, the disease duration was of mean 47.6 ± 26.56 months, and mean age was 31.32 ± 8.85. Serum and urinary iron biomarkers were significantly higher in SLE patients compared to controls except for iron which was lower in lupus patients with similar significant difference between patients subgroups. TfR gene expression in renal tissue didn’t significantly differ across LN classes. Tubular iron deposition was observed histopathologicaly. Urinary transferrin showed significant correlation with activity score and proteinuria (r = 0.94, r = 0.43 and p < .0001, p = .03) while serum TfR significantly correlated with disease activity and ESR (r = 0.61, r = 0.4 and p < .0001, p = .03, respectively). TfR gene expression on renal tissue did not correlate with urinary transferrin, disease activity or other laboratory parameters. Conclusions: Elevated urinary transferrin and serum TfR correlated with disease activity in lupus population and may serve as a potential non-invasive biomarker for lupus nephritis.Keywords
This publication has 26 references indexed in Scilit:
- Serum ferritin, transferrin and metabolic syndrome are risk factors for subclinical atherosclerosis in Egyptian women with systemic lupus erythematosus (SLE)The Egyptian Rheumatologist, 2019
- Erythrocyte and glomerular C4d deposits as a biomarker for active lupus nephritisThe Egyptian Rheumatologist, 2018
- International validation of a urinary biomarker panel for identification of active lupus nephritis in childrenPediatric Nephrology, 2016
- Urinary podocalyxin and nephrin levels as biomarkers in lupus nephritis patients: Relation to renal involvement and disease activityThe Egyptian Rheumatologist, 2016
- Interleukin 17 signaling drives Type I Interferon induced proliferative crescentic glomerulonephritis in lupus-prone miceClinical Immunology, 2016
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosusArthritis & Rheumatism, 2012
- Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritisArthritis & Rheumatism, 2012
- Multiethnic lupus cohorts: What have they taught us?Reumatología Clínica, 2011
- Pathogenesis of human systemic lupus erythematosus: recent advancesTrends in Molecular Medicine, 2010
- Neutrophil gelatinase–associated lipocalin is a predictor of the course of global and renal childhood‐onset systemic lupus erythematosus disease activityArthritis & Rheumatism, 2009